Overview
Chronic active hepatitis (CAH) is a progressive liver disease characterized by ongoing hepatocellular inflammation and necrosis, often associated with autoimmune mechanisms 1.Diagnosis
Autoantibodies may indicate autoimmune involvement; specific antibodies targeting cancer antigens and calmodulin conformations should be considered 12.
Serological testing for autoantibodies, including those specific to calmodulin, can aid in diagnosis 2.
Clinical presentation may include associated dermatological manifestations such as pyoderma gangrenosum 3.Management
Corticosteroids like prednisolone are effective for managing complications such as pyoderma gangrenosum 3.
Specific dosing details for corticosteroids are not provided; individualized treatment based on severity is recommended.
Further immunosuppressive agents may be necessary depending on disease activity and response to initial therapy 3.Special Populations
Pregnancy: No specific data provided in the abstracts.
Pediatrics: No specific data provided in the abstracts.
Elderly: No specific data provided in the abstracts.
Comorbidities: Presence of cirrhosis may influence management, particularly with regard to immunosuppressive therapy 3.Key Recommendations
Consider serological testing for autoantibodies, including those specific to calmodulin conformations, in diagnosing autoimmune chronic active hepatitis (Evidence: Moderate 2).
Initiate corticosteroid therapy, such as prednisolone, for managing complications like pyoderma gangrenosum (Evidence: Weak 3).
Tailor immunosuppressive treatment based on disease activity and response, considering potential complications like cirrhosis (Evidence: Expert opinion).References
1 Fischer KM. Auto-antibodies in chronic active hepatitis may bind to cancer antigens. Medical hypotheses 1989. link90119-9)
2 Ikeda Y, Toda G, Hashimoto N, Maruyama T, Oka H. Antibody that recognizes conformations of calmodulin in the serum from patient with chronic active hepatitis. Biochemical and biophysical research communications 1987. link80494-1)
3 Marshall AW, Slonim JM, Smallwood RA, Fraser KJ. The association of chronic active hepatitis with pyoderma gangrenosum. Australian and New Zealand journal of medicine 1978. link